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E. A. BARLEY, F. H. QUIRK AND P. W. JONES 
Division of Physiological Medicine, St. George’s Hospital Medical School, London, U.K. 
Health status (Quality of Life) questionnaires for use in asthma are generally too long or complex for routine use. 
A new short and simple measure of health status in asthma has been developed for this purpose. There are two 
versions, one containing 30 items (AQ30) and the other 20 items (AQ20). This study examined their cross-sectional 
and longitudinal properties and compared them with those of two established measures-the St. George’s 
Respiratory Questionnaire (SGRQ) and the Asthma Quality of Life Questionnaire (AQLQ). 
Ninety asthmatic patients (mean age 46 years) participated. Mean post-bronchodilator forced expiratory volume 
in one second (FEV,) was 73 ZIZ 25 (SD) % predicted at baseline. Questionnaire data were collected twice, 12 weeks 
apart. Diary records of peak expiratory flow rate (PEFR) and daily asthma were kept for 14 days. 
The new questionnaires each took 3 min or less to complete. At baseline they correlated well with the SGRQ and 
AQLQ and showed the same pattern of correlations with clinical measures of asthma. Change scores for the new 
questionnaires correlated with those for the established measures. There was no advantage of the AQ30 over the 
AQ20. 
The AQ20 provides a simple method for obtaining valid health status estimates of asthmatics in routine clinical 
practice and has properties similar to more complex research instruments. 
RESPIR. MED. (1998) 92, 1207-1214 
Introduction 
Quality of life (QoL) questionnaires have proved useful in 
clinical trials of asthma (1). However, strictly speaking, 
these should be referred to as health status measures, 
since QoL generally refers to a construct that is specific to 
an individual, whereas the most common measures are 
standardised and designed to measure the health of popu- 
lations. There is now increasing interest as to how these 
measures can be used in clinical practice (2). Various 
applications have been suggested, including the monitor- 
ing and early detection of problems and the setting of 
treatment goals. The routine use of health status measures 
may also facilitate the integration of clinical practice and 
research. Few empirical studies have addressed the clinical 
use of such measures, but it has been reported that 
patients felt that the information elicited by one measure 
was important for the doctor to know. Similarly, physi- 
cians reported that it provided them with new information 
(3). 
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The major barriers to health status measurement in 
clinical practice are the size and complexity of the instru- 
ments. To remove these barriers and permit a test of the 
utility of health status measurement in routine care a new 
simple questionnaire has been developed. A detailed 
description of its development within a sample of asthmatic 
and COPD patients can be found elsewhere (4). Essentially, 
it is comprised of items selected for their correlation with 
global health or global perceived severity of airways disease 
and absence of correlation with age, sex, duration of disease 
or diagnosis of asthma or COPD. Principal components 
analysis was used to identify core items. To determine the 
minimum number of items that may be used without 
compromising the measurement properties of the question- 
naire, two versions were developed. The AQ30 which 
contains 30 items and the AQ20 which contains 20 of the 
items present in the AQ30. Repeatability and validity has 
been demonstrated over 2 weeks in patients with asthma or 
COPD (5). The purpose of this study was to examine the 
comparative cross-sectional and longitudinal measurement 
properties of the two versions within an asthmatic popula- 
tion. The performance of the new measures was compared 
with that of two established airways specific health status 
measures - the St George’s Respiratory Questionnaire 
(SGRQ) (6) and the Asthma Quality of Life Questionnaire 
(AQLQ) (7). 
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Methods 
PATIENTS 
Patients were recruited from two South London hospital 
outpatient asthma clinics. Ninety patients (59 female), with 
a diagnosis of asthma made by a consultant respiratory 
physician, agreed to participate. Patients with additional 
medical conditions considered to impact upon health status 
were excluded. Patients were aged between 17 and 79 years 
(mean 46). Their mean post-bronchodilator forced expira- 
tory volume in one second (FEV,) was 73 f 25 (SD) % 
predicted (% pred). The range in FEV, was 14130% pred. 
The mean daily variation in peak expiratory flow rate 
(PEFR) was 16 & 14 (SD) %. All patients were prescribed a 
beta-2 agonist bronchodilator and an inhaled steroid, 
except for one patient who was receiving an inhaled steroid 
alone and another receiving only a beta-2 agonist. Forty- 
one patients had never smoked, 19 were current and 30 
were ex-smokers. Ethical approval for the study was pro- 
vided by Wandsworth Health Authority Local Research 
Ethics Committee. Written consent was obtained from all 
patients. 
HEALTH STATUS MEASURES 
The new questionnaires have either 20 items (AQ20) or 30 
items (AQ30) (4). The items of the AQ20 form a subset of 
the AQ30 items (see Appendix). Response to each item 
takes the form ‘Yes’, ‘No’ or ‘Not applicable’. Positive 
responses only are scored and then summed to provide a 
total score out of 20 (AQ20) or 30 (AQ30). 
The SGRQ (6) is a standardised measure of airways 
specific health status designed for supervised self comple- 
tion. It has empirically produced item weights and provides 
a Total and three component scores: Symptoms; Activity; 
and Impacts. Each score ranges from 0 to 100, where 
lOO=worst health. 
The AQLQ (7) provides a Total and four component 
scores: Activities; Symptoms; Emotional Functioning; and 
Environmental Stimuli. The Activities component is par- 
tially individualised in that patients select which activities 
are used. The interviewer-administered version was used in 
the present study. At follow up, patients are informed of 
their previous response. All scores range from 1 (worst 
health) to 7 (best health). 
CLINICAL VARIABLES 
Spiuometry 
Point estimates of post-bronchodilator FEV, and forced 
vital capacity (FVC) were measured using a portable 
spirometer. The best of three attempts was recorded. 
Diary cards eliciting the following clinical variables were 
completed over 14 days. 
Peak Expivatouy Flow Rate (PEFR) 
Patients recorded their PEFR twice a day. The highest of 
three attempts was entered. To ensure standardisation 
between patients, morning measurements were recorded 
before medication and evening measurements after medica- 
tion. Mean values over the 14 days were calculated for each 
patient. Daily variation was calculated as amplitude % 
mean=(highest - lowest/mean) x 100. 
Daily Asthma 
Each evening, patients answered two general questions 
regarding their asthma: 
(i) ‘How has your asthma been today?’ (Asthma Severity) 
(ii) ‘How much effect has your asthma had on your life 
today?’ (Asthma Impact). 
For each, patients selected one of six possible responses: 
none=O; very mild=l; mild=2; moderate=3; severe=4; 
very severe= 5. A mean score over the 14 days was 
calculated for each patient. 
Sleep Disturbance 
Each morning, patients answered ‘yes’ or ‘no’ to the 
question ‘Has your sleep been disturbed by your cough or 
breathing?‘. The average number of disturbed nights per 
week was calculated. 
Bronckodilator Use 
Each evening, patients recorded the number of puffs taken 
in the last 24 h. A daily mean over the 14 days was 
calculated. 
STUDY DESIGN 
Patients were seen twice, 12 weeks apart. On each occasion 
spirometric data were recorded and they completed the 
AQ20/30, the SGRQ and the AQLQ. The order of presen- 
tation was randomised using a Latin square. The time taken 
to complete each questionnaire was noted. Spirometry, 
demographic data and self-reported information on the 
number of years since receiving a diagnosis of asthma 
(disease duration) were collected at baseline. Diary cards 
were completed over the 14 days following the baseline 
interview. 
ANALYSIS 
Cross-sectional 
Ease of use was examined by comparing the mean question- 
naire completion times. The distribution of scores for the 
four health status measures were compared to test for floor 
or ceiling effects. Concurrent validity was tested by calcu- 
lating the correlations (r) between the new and the estab- 
lished measures (SGRQ, AQLQ). Convergent validity was 
tested by examining the degree of association between the 
new questionnaires and the clinical variables. Relationships 
with gender, age and disease duration were also examined. 
Simultaneous analyses were made for the purpose of com- 
parison using the Total scores of the established measures. 
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FIG. 1. Frequency distributions of patients’ responses to four health status measures at baseline. 
Longitudinal 
Change scores for the health status measures were calcu- 
lated by subtracting the score at Time 2 from that at Time 
1. The comparative sensitivity to change of the two new 
measures was tested by calculating the correlations between 
the change scores for each and those of the SGRQ and 
AQLQ total. Summary data are expressed as mean + SD. 
All lung function data are expressed as a percentage of 
predicted values (8). 
CROSS-SECTIONAL ANALYSIS 
Data Collection 
At baseline spirometry and questionnaire data were col- 
lected from 90 patients, although four patients did not 
complete the AQLQ because they were unable to list any 
activities in which they felt limited. Diary cards were 
returned by 74 patients, some with data missing in part. 
Data for a variable was considered ‘missing’ if less than 7 
days had been completed. The final number of complete 
variables was: PEFR n=74; Asthma Severity n=74; 
Asthma Impact n=69; Sleep disturbance n=73; Broncho- 
dilator use n=73. 
Ease of Use 
The AQ20 and AQ30 took an average of 2.5 & 0.9 and 
3.0 f 1.1 min to complete (respectively). The SGRQ 
required 8.2 & 3.9 min. The AQLQ took 12.6 & 3.2min 
at baseline and 7.0 * 2.0 min at follow-up, when the 
administration is simpler due to the use of individualised 
information elicited at baseline. 
Distribution of Scores 
Frequency distributions for the scores for the new question- 
naires and the Total scores of the SGRQ and the AQLQ are 
shown in Fig. 1. With the AQ20 and the AQ30, a ceiling 
effect was seen for one patient (best health=O), but there 
were no floor effects. Neither floor nor ceiling effects were 
found for the Total scores of either the SGRQ or the 
AQLQ. 
The SGRQ scores were normally distributed but the 
AQ20, AQ30 and AQLQ scores were skewed towards high 
scores, but with opposite implications due to their methods 
of scoring. The AQ20 and AQ30 tended to indicate poorer 
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TABLE 1. Correlations (Pearson’s v) between the new ques- 
tionnaires and the established measures at baseline 
AQ30 AQ20 
The level of correlation between the AQ20/30 and morning 
PEFR was akin to that observed between morning PEFR 
and AQLQ Total score but lower than that found between 
morning PEFR and SGRQ Total score (Table 2). 
SGRQ - Symptoms 
SGRQ - Activity 
SGRQ - Impacts 
SGRQ - Total 
AQLQ - Activities 
AQLQ - Symptoms 
AQLQ - Emotional Functioning 
AQLQ - Environmental Stimuli 
AQLQ - Total 
WO.0001 in all cases. 
0.73 0.73 
0.74 0.75 
0.82 0.81 
0.86 0.86 
- 0.72 - 0.71 
- 0.77 - 0.78 
- 0.59 - 0.56 
- 0.66 - 0.67 
- 0.80 - 0.80 
Daily Asthma. Correlations with the diary card 
measures of Asthma Severity and Asthma Impact were the 
same for both new questionnaires (Table 2). Comparable 
relationships were found between both measures of daily 
asthma and the Total scores of the established question- 
naires (Table 2). Asthma Severity and Asthma Impact were 
correlated (v=O.86, WO.0001). 
Sleep Disturbance. Fifty-four patients reported some 
disturbance. Both new questionnaires were correlated to the 
same extent with sleep disturbance (Table 2). Total scores 
for the established questionnaires correlated with sleep 
disturbance at a similar level (Table 2). 
health, whilst the AQLQ scores indicated predominantly 
less impaired health. 
Bronchodilator Use. Correlations with the new ques- 
tionnaires were similar. The level of correlation was com- 
parable to that between the Total scores from the 
established measures and bronchodilator use (Table 2). 
Correlation Between Health Status Measures Relationship with Patient Characteristics 
Both new questionnaires correlated well with the SGRQ 
and the AQLQ (Table 1). The new questionnaires corre- 
lated better with the Total than with the component scores 
of the established measures. The weakest correlations were 
with the AQLQ Emotional Functioning and Environmental 
Stimuli components. 
Relationship with Clinical Variables 
Lung Function. The AQ20 and the AQ30 were corre- 
lated similarly with PEFR (am and pm) but not FEV, or 
FVC (Table 2). The new questionnaires correlated with 
daily PEFR variation to a similar degree, although the 
correlation with the AQ30 just failed to reach significance. 
Scores for both new measures were significantly worse in 
women (AQ30 difference=2.9, P=O.O5; AQ20 differ- 
ence=2,3, P=O.O3). This was also the case for the Total 
scores of the SGRQ (difference=9.8, P=O.O3) and the 
AQLQ (difference=0.6, P=O.O4). This was despite the 
women having significantly better lung function (males, 
mean = 59 & 20% pred.; females, mean = 80 + 24% pred.; 
P<O.OOOl). Neither of the new measures nor the AQLQ 
Total score were significantly correlated with age. However, 
the SGRQ Total score was found to increase with age 
(r=O.25, P=O.O2). Neither the new nor the established 
measures were correlated with disease duration, whether it 
was expressed in years or as the percentage of life spent with 
diagnosed asthma. 
TABLE 2. Correlations (Pearson’s r) between the health status measures and clinical variables at 
baseline 
SGRQ AQLQ 
AQ30 AQ20 Total Total 
FEV, 
FVC 
Morning PEFR 
Evening PEFR 
Daily variation PEFR 
Asthma Severity 
Asthma Impact 
Sleep disturbance 
Bronchodilator use 
Age 
Disease duration 
- 0.09 n.s. - 0.11 n.s. - 0.23* 0.17 n.s. 
- 0.12 n.s. - 0.16 n.s. - 0.26? 0.24” 
- 0.28” - 0.30? - 0.455 0.34? 
- 0.27* - 0.29t - 0.4125 0.21 n.s. 
0.21 n.s. 0.23* 0.30t - 0.42$ 
0.57s 0.575 0.61s - 0.625 
0.645 0.645 0.655 - 0.655 
0.525 0.515 0.495 - 0.445 
0.34? 0.32? 0.378 - 0.34? 
0.16 n.s. 0.16 n.s. 0.25* - 0.09 n.s. 
- 0.00 n.s. - 0.01 n.s. 0.03 n.s. 0.06 ns. 
n.s. PBO.05; *P<O.O5; tP<O.Ol; $P<O.OOl; $P<O.OOOl. 
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FIG. 2. Frequency distributions of patients’ change scores (A) on four health status measures. Change scores were calcu- 
lated by deducting the score from Time 1 from that of Time 2. They are expressed as a percentage of their scoring range 
to allow comparison between measures. 
LONGITUDINAL ANALYSIS 
Follow up questionnaire and FEV, data were collected 
from 81 patients. Mean post bronchodilator FEV, was 
71 & 26 (SD) % pred., there was no significant difference in 
FEV, between baseline and follow up (t-test P>O.O5). 
Distribution of Change Scores 
The distribution of change scores for the health status 
measures is depicted in Fig. 2. The variation in AQ20, 
AQ30 and the SGRQ Total scores was similar and more 
than that shown by the AQLQ which showed a distinct 
peak for ‘no change’. 
Correlation Between Health Status Measure Change 
Scores 
The change scores for both new questionnaires were corre- 
lated with change scores for the SGRQ Total (u=O.46, 
P<O.OOOl for both) and the AQLQ Total (AAQ30 
Y= - 0.31, PcO.01; AAQ20 Y= - 0.40, P<O.OOl) (Fig 3). 
Change scores for the new questionnaires also correlated 
with those of the components of the established measures, 
except that the AQ30 change score did not correlate with 
that for the AQLQ Environmental Stimuli component. 
Correlations tended to be greater with Total rather than 
component scores. 
Discussion 
The AQ20 and AQ30 were found to be easy to administer 
and score. They required 3 min or less to administer and 
score. They correlated well with two more complex research 
instruments and showed a pattern and magnitude of corre- 
lations with the clinical measures of asthma very similar to 
that obtained with the established measures. Thus, the new 
and the established measures appear to produce compar- 
able valid estimates of health status. The frequency distri- 
bution of the new questionnaires showed a slight skew 
towards higher scores (i.e. worse health) in contrast to the 
AQLQ which exhibited a similar skew, but towards good 
health. The SGRQ scores were normally distributed in the 
middle of the scoring range. Like the SGRQ, the AQ20 and 
AQ30 scores appear to use most of their potential scoring 
ranges. This was similar to the distribution in the FEV, 
data. The range of asthma severity was wide (FEV, 
range= 14130% pred), with 67% of patients having a post 
bronchodilator FEV, less than 95% pred. AQLQ scores 
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FIG. 3. Relationship (Pearson’s v) between the change scores (A) of the new questionnaires and those of the established 
measures. 
were confined to a more limited part of its range at the 
milder end. Overall, the new questionnaires performed 
similarly to the Total scores of the longer questionnaires 
rather than their component scores. 
It may be argued that the correlations between the AQ20 
and AQ30 and the SGRQ and AQLQ are unsurprising, 
since the new questionnaires are comprised of items derived 
from five existing instruments, including the SGRQ and 
AQLQ. However, the items forming the new questionnaires 
were selected from the total item pool using detailed item 
analysis and were those found to have the greatest discrimi- 
natory powers (4). The AQ20 contains only one item very 
similar to one in the SGRQ and six items similar to ones in 
the AQLQ. The AQ30 contains one further item that was 
similar to one in the AQLQ. Furthermore, our objective in 
testing the correlations between the new and established 
instruments was to test whether the results produced by 
them would be comparable, which we have shown to be the 
case. 
A previous study showed that the AQ20 and the AQ30 
have high levels of short term repeatability (intraclass 
correlation coefficient=0.9, both) (5). To test sensitivity to 
change in the current study, we utilised the spontaneous 
variation that normally occurs in an asthmatic population. 
Since the patients were recruited from a clinic in which their 
status was closely monitored, changes in their level of 
asthma were quite small and there was no difference in 
FEV, between baseline and follow up. This provided only a 
limited range over which to test correlations. When looking 
at the distribution of change scores, the AQ20 and the 
AQ30 showed a relatively normal distribution as did the 
SGRQ, but the AQLQ was very peaked around ‘no 
change’. Changes in AQ20130 scores correlated quite well 
with changes in the Total scores for the SGRQ and AQLQ, 
despite the relatively small range of changes over which 
such associations could be tested. 
In all the tests, both longitudinal and cross-sectional, the 
AQ20 and the AQ30 were found to perform very similarly 
to each other. The ten additional items in the AQ30 appear 
to add little to the information obtained with the twenty 
item version. The study has shown that a simple 20 item 
questionnaire can produce a valid, standardised estimate of 
the health status of asthmatic patients comparable to that 
obtained using a longer more time-consuming measure. It 
also appears to be sensitive to change in a manner similar to 
more complex measures. The ease of use of the AQ20 
means that it is clearly suitable for routine use in a range 
of clinical settings. No special training is required for 
those administering it and patients are able to complete it 
unsupervised. The development and validation of the AQ20 
now permits a test of the utility of health status measure- 
ment in the routine care of patients with asthma. 
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Appendix - The AQtOIAQ30 
(The AQ20 comprises the first 20 items. A ‘Yes’ response is scored ‘I’, ‘No’ and ‘N/A’ responses are scored ‘O’.) 
The following questions are concerned with the effect of your chest trouble on your everyday life. Please respond ‘Yes’, ‘No’ - _ 
or ‘Not Applicable’ (N/A) to each item. 
Yes 
(1) Do you suffer from coughing attacks during the day? 0 
(2) Because of your chest trouble do you often feel restless? 0 
(3) Because of your chest trouble do you feel breathless maintaining the garden? 0 
(4) Do you worry when going to a friend’s house that there might be something there that 0 
will set off an attack of chest trouble? 
(5) Do you suffer from chest symptoms as a result of exposure to strong smells, cigarette smoke or o 
(6) 
(7) 
(8) 
(9) 
(10) 
(11) 
(12) Do you feel breathless walking upstairs because of your chest trouble? 
(13) Because of your chest trouble do you suffer from breathlessness doing housework? 
(14) Because of your chest trouble do you go home sooner than others after a night out? 
(15) Because of your chest trouble do you suffer from breathlessness when you laugh? 
(16) Because of your chest trouble do you often feel impatient? 
(17) Because of your chest trouble do you feel that you cannot enjoy a full life? 
(18) Do you feel drained after a cold because of your chest trouble? 
(19) Do you have a feeling of chest heaviness? 
(20) Do you bother much about your chest trouble? 
(21) Do you have difficulty taking part in sports because of your chest trouble? 
(22) Do you worry about getting an attack of chest trouble even when you are well? 
(23) Are you embarrassed by heavy breathing? 
(24) Does your chest trouble affect you other than when you are having an attack? 
(25) Do you do all the things you want to regardless of the effects on your chest trouble? 
(26) Because of your chest trouble do you often feel helpless? 
(27) Do you work badly when your chest trouble is bad? 
(28) Because of your chest trouble do you have difficulty doing housework? 
(29) Is your sex life affected by your chest trouble? 
(30) Do you suffer from discomfort when you cough? 
perfume? 
Is your partner bothered by your chest trouble? 
Do you feel breathless while trying to sleep? 
Do you worry about the long term effects on your health of the drugs that you have to take 
because of your chest trouble? 
Does getting emotionally upset make your chest trouble worse? 
Because of your chest trouble are there times when you have difficulty getting around 
the house? 
Because of your chest trouble do you suffer from breathlessness carrying out activities 
at work? 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
No N/A 
0 0 
0 0 
0 0 
0 0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
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0 
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0 
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0 
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